Use of mesenchymal stem cells for therapy of cardiac disease.
Ontology highlight
ABSTRACT: Despite substantial clinical advances over the past 65 years, cardiovascular disease remains the leading cause of death in America. The past 15 years has witnessed major basic and translational interest in the use of stem and precursor cells as a therapeutic agent for chronically injured organs. Among the cell types under investigation, adult mesenchymal stem cells are widely studied, and in early stage, clinical studies show promise for repair and regeneration of cardiac tissues. The ability of mesenchymal stem cells to differentiate into mesoderm- and nonmesoderm-derived tissues, their immunomodulatory effects, their availability, and their key role in maintaining and replenishing endogenous stem cell niches have rendered them one of the most heavily investigated and clinically tested ty
SUBMITTER: Karantalis V
PROVIDER: S-EPMC4429294 | biostudies-literature | 2015 Apr
REPOSITORIES: biostudies-literature
ACCESS DATA